Douglas Scharre, MD
Enriched profileDirector, Division of Cognitive and Memory Disorders; Professor of Clinical Neurology and Psychiatry · The Ohio State University Wexner Medical Center
Douglas Scharre is Director, Division of Cognitive and Memory Disorders; Professor of Clinical Neurology and Psychiatry at The Ohio State University Wexner Medical Center. OpenAlex indexes 255 publications with 15,652 citations (h-index 57); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 14 Oct 2026
Overview
Updated 14 Oct 2026
Douglas Scharre, MD, is Director, Division of Cognitive and Memory Disorders at The Ohio State University Wexner Medical Center. The public record shows 255 publications with 15,652 citations (h-index 57), centered on Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2024–2025).
- Most recent indexed publication: 2026 · JMIR research protocols
- Top research focus: Dementia and Cognitive Impairment Research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 140.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Medical Director
Ohio State University Center for Cognitive and Memory Disorders
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Sponsor: Novartis Pharmaceuticals
- LH-001 vs Placebo in Healthy Participants
Sponsor: Chien-Liang Lin
Industry payments
Updated 14 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20259 payments$15,430openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year20254 payments$12,068openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.5%Cholinesterase Inhibitor26.2%Donepezil Hcl75%Galantamine Er13%Rivastigmine8%Galantamine Hbr4%Part D<11 patientsSSRI21.5%Sertraline Hcl31%Trazodone Hcl27%Fluvoxamine Maleate26%Escitalopram Oxalate16%Part D<11 patients+ 13 more classes in this area
Cardiovascular
0.9%Statin0.9%Atorvastatin Calcium100%Part D<11 patientsDermatology
0.6%Corticosteroid0.6%Methylprednisolone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved
Ohio State University
FY2025$738,977R01AG082044 - Integrating eSAGE with EHR data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved
Ohio State University
FY2024$762,126R01AG082044
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Discriminating memory disordered patients from controls using diffusion model parameters from recognition memory.
Journal of experimental psychology. General
Article2022
Most-cited works
by citation count (OpenAlex)- 01Donanemab in Early Symptomatic Alzheimer DiseaseArticle2,857 citations2023
- 02
- 03
- 04Spread of pathological tau proteins through communicating neurons in human Alzheimer’s diseaseArticle518 citations2020
- 05Predicting Alzheimer’s disease progression using multi-modal deep learning approachArticle401 citations2019
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
cog.osu.edu/people/scharre.1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cog.osu.edu ↗ - Other
medicine.osu.edu/find-a-researcher/douglas-scharre-100000060
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.osu.edu ↗ - Other
practicalneurology.com/profiles/douglas-w-scharre-md/LAJzw4/affiliations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →practicalneurology.com ↗ - Other
reachmd.com/profiles/douglas-scharre-md-cmd/7rk85j/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
Mentions by others
where others cite or feature them- Other
wexnermedical.osu.edu/neurological-institute/neurology/our-team/cognitive-and-memory-disorders
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wexnermedical.osu.edu ↗ - YouTube
podcastaddict.com/episode/https%3A%2F%2Fdts.podtrac.com%2Fredirect.mp3%2Ftraffic.libsyn.com%2Fsecure%2Fgolyproject%2Fscharre.mp3%3Fdest-id%3D2765309&podcastId=6164104
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcastaddict.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alz.org ↗
- Fellow
American Academy of Neurology (FAAN)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.osu.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lbda.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radio.foxnews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Raphael Pollock, MD, PhD
The Ohio State University Wexner Medical Center
John Kissel, MD
The Ohio State University Wexner Medical Center
Kathleen Dungan, MD
The Ohio State University Wexner Medical Center
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida